These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27556126)

  • 1. Response.
    Rosenkrantz AB; Kang SK; Kierans AS
    Radiology; 2016 May; 279(2):652. PubMed ID: 27556126
    [No Abstract]   [Full Text] [Related]  

  • 2. [5. Inspection of Hepatocellular Carcinoma 3-Contrast for the Diagnosis of Hepatocellular Carcinoma: Techniques of Image Contrast and the Choice of MR Contrast Agent].
    Kitoh Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 May; 72(5):441-51. PubMed ID: 27211090
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of Small Hepatocellular Carcinoma.
    Civan JM
    Radiology; 2016 May; 279(2):651-2. PubMed ID: 27089193
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular carcinoma: contrast-enhanced MRI.
    Yu JS; Kim MJ
    Abdom Imaging; 2002; 27(2):157-67. PubMed ID: 11847575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dynamic MRI].
    Araki T; Ichikawa T; Nakajima H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
    [No Abstract]   [Full Text] [Related]  

  • 6. Receiver operating characteristic curve analysis, sensitivity comparison and individual difference.
    Kawada T
    Clin Radiol; 2012 Sep; 67(9):940. PubMed ID: 22608247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-contrast MR Imaging for Hepatocellular Carcinoma].
    Han JK; Kim SH
    Korean J Hepatol; 2006 Jun; 12(2):247-50. PubMed ID: 16804351
    [No Abstract]   [Full Text] [Related]  

  • 8. Will CT take second billing to MR imaging for the diagnosis of hypervascular hepatocellular carcinomas hereafter?
    Kanematsu M
    Radiology; 2011 Aug; 260(2):607; author reply 607-8. PubMed ID: 21778455
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatocellular carcinoma and other hepatic malignancies: MR imaging.
    Roth CG; Mitchell DG
    Radiol Clin North Am; 2014 Jul; 52(4):683-707. PubMed ID: 24889167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging in cirrhosis and hepatocellular carcinoma.
    Barr DC; Hussain HK
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
    van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
    Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI in the evaluation of hepatocellular nodules: role of pulse sequences and contrast agents.
    Ichikawa T
    Intervirology; 2004; 47(3-5):252-70. PubMed ID: 15383734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cirrhosis and pre-neoplastic lesions.
    Grazioli L; Olivetti L; Orlando E
    Abdom Imaging; 2012 Apr; 37(2):188-214. PubMed ID: 22297506
    [No Abstract]   [Full Text] [Related]  

  • 14. Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.
    Pastor CM
    Radiology; 2010 Nov; 257(2):589. PubMed ID: 20959554
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
    Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA
    J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients.
    Chachuat A; Bonnemain B
    Radiologe; 1995 Nov; 35(11 Suppl 2):S274-6. PubMed ID: 8588035
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 19. Imaging after local tumor therapies: kidney and liver.
    Kielar AZ; Hibbert RM; Maturen KE
    Semin Roentgenol; 2013 Jul; 48(3):273-84. PubMed ID: 23796378
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocellular carcinoma.
    Seynaeve P; Desimpelaere J; De Surgeloose D; Appel B; Mortelmans LL
    J Belge Radiol; 1997 Dec; 80(6):313. PubMed ID: 9479911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.